Skip to Main Content

Author Details

Gabriele Neumann
Influenza Research Institute, University of Wisconsin-Madison
1993
171
58
PMIDPaper TitleJournal TitlePublished Year
36821715Interim Estimates of 2022-23 Seasonal Influenza Vaccine Effectiveness - Wisconsin, October 2022-February 2023.MMWR Morb Mortal Wkly Rep2023
37631932Development of an Enhanced High-Yield Influenza Vaccine Backbone in Embryonated Chicken Eggs.Vaccines (Basel)2023
37622664Annual (2023) taxonomic update of RNA-directed RNA polymerase-encoding negative-sense RNA viruses (realm <i>Riboviria</i>: kingdom <i>Orthornavirae</i>: phylum <i>Negarnaviricota</i>).J Gen Virol2023
37515281Continued Circulation of Highly Pathogenic H5 Influenza Viruses in Vietnamese Live Bird Markets in 2018-2021.Viruses2023
37812908Characterization of highly pathogenic clade 2.3.4.4b H5N1 mink influenza viruses.EBioMedicine2023
37112710Quadrivalent Formulation of Intranasal Influenza Vaccine M2SR (M2-Deficient Single Replication) Protects against Drifted Influenza A and B Virus Challenge.Vaccines (Basel)2023
37243179Highly Pathogenic H5 Influenza Viruses Isolated between 2016 and 2017 in Vietnamese Live Bird Markets.Viruses2023
37376452Intranasal Single-Replication Influenza Vector Induces Cross-Reactive Serum and Mucosal Antibodies against SARS-CoV-2 Variants.Vaccines (Basel)2023
37466314Influenza H3 hemagglutinin vaccine with scrambled immunodominant epitopes elicits antibodies directed toward immunosubdominant head epitopes.mBio2023
36851516The COVID-19 Pandemic-A Potential Role for Antivirals in Mitigating Pandemics.Viruses2023
36517323Ferret model to mimic the sequential exposure of humans to historical H3N2 influenza viruses.Vaccine2023
36875208Effectiveness of first and second COVID-19 mRNA vaccine monovalent booster doses during a period of circulation of Omicron variant sublineages: December 2021-July 2022.Influenza Other Respir Viruses2023
36680238Which Virus Will Cause the Next Pandemic?Viruses2023
34323977M2-Deficient Single-Replication Influenza Vaccine-Induced Immune Responses Associated With Protection Against Human Challenge With Highly Drifted H3N2 Influenza Strain.J Infect Dis2022
35458458Characterization of H9N2 Avian Influenza Viruses Isolated from Poultry Products in a Mouse Model.Viruses2022
35862762Robustness of the Ferret Model for Influenza Risk Assessment Studies: a Cross-Laboratory Exercise.mBio2022
364374282022 taxonomic update of phylum Negarnaviricota (Riboviria: Orthornavirae), including the large orders Bunyavirales and Mononegavirales.Arch Virol2022
36560540Longevity and Mechanism of Heterosubtypic Protection Induced by M2SR (M2-Deficient Single-Replication) Live Influenza Virus Vaccine in Mice.Vaccines (Basel)2022
35893694Influenza Viruses Suitable for Studies in Syrian Hamsters.Viruses2022
36350017Intranasal M2SR (M2-Deficient Single Replication) H3N2 Influenza Vaccine Provides Enhanced Mucosal and Serum Antibodies in Adults.J Infect Dis2022
35157360Seasonality of influenza and other respiratory viruses.EMBO Mol Med2022
35178857mRNA COVID-19 vaccine effectiveness against SARS-CoV-2 infection in a prospective community cohort, rural Wisconsin, November 2020 to December 2021.Influenza Other Respir Viruses2022
34875072SARS-CoV-2 Interference of Influenza Virus Replication in Syrian Hamsters.J Infect Dis2022
35336970A Novel Method to Reduce ELISA Serial Dilution Assay Workload Applied to SARS-CoV-2 and Seasonal HCoVs.Viruses2022
33411764Novel modulators of p53-signaling encoded by unknown genes of emerging viruses.PLoS Pathog2021
33563825Plasticity of the Influenza Virus H5 HA Protein.mBio2021
33536277Development and deployment of COVID-19 vaccines for those most vulnerable.Sci Transl Med2021
34872354H3N2 Influenza Viruses with 12- or 16-Amino Acid Deletions in the Receptor-Binding Region of Their Hemagglutinin Protein.mBio2021
34960134Safety and Immunogenicity of M2-Deficient, Single Replication, Live Influenza Vaccine (M2SR) in Adults.Vaccines (Basel)2021
344638772021 Taxonomic update of phylum Negarnaviricota (Riboviria: Orthornavirae), including the large orders Bunyavirales and Mononegavirales.Arch Virol2021
31964649Influenza Reverse Genetics-Historical Perspective.Cold Spring Harb Perspect Med2021
32287326Characterizing Emerging Canine H3 Influenza Viruses.PLoS Pathog2020
31801857Mutations in the Neuraminidase-Like Protein of Bat Influenza H18N11 Virus Enhance Virus Replication in Mammalian Cells, Mice, and Ferrets.J Virol2020
328880502020 taxonomic update for phylum Negarnaviricota (Riboviria: Orthornavirae), including the large orders Bunyavirales and Mononegavirales.Arch Virol2020
32528005Identification of interferon-stimulated genes that attenuate Ebola virus infection.Nat Commun2020
32145878Optimization of animal models to better predict influenza vaccine efficacy (VA).Vaccine2020
30715371Predicting the Next Influenza Pandemics.J Infect Dis2019
31293548Isolation of Highly Pathogenic H5N1 Influenza Viruses in 2009-2013 in Vietnam.Front Microbiol2019
31399519A Novel Vaccine Strategy to Overcome Poor Immunogenicity of Avian Influenza Vaccines through Mobilization of Memory CD4 T Cells Established by Seasonal Influenza.J Immunol2019
31369554Serological analysis of Ebola virus survivors and close contacts in Sierra Leone: A cross-sectional study.PLoS Negl Trop Dis2019
31280945Single-replication BM2SR vaccine provides sterilizing immunity and cross-lineage influenza B virus protection in mice.Vaccine2019
29186472Combination Therapy With Neuraminidase and Polymerase Inhibitors in Nude Mice Infected With Influenza Virus.J Infect Dis2018
29941581In vivo imaging of the pathophysiological changes and neutrophil dynamics in influenza virus-infected mouse lungs.Proc Natl Acad Sci U S A2018
29912683Diversity of Influenza A(H5N1) Viruses in Infected Humans, Northern Vietnam, 2004-2010.Emerg Infect Dis2018
30151587Selection of Antigenically Advanced Variants of Influenza Viruses.Methods Mol Biol2018
30258431The Cellular DExD/H-Box RNA Helicase UAP56 Co-localizes With the Influenza A Virus NS1 Protein.Front Microbiol2018
30226171Effectiveness of Whole, Inactivated, Low Pathogenicity Influenza A(H7N9) Vaccine against Antigenically Distinct, Highly Pathogenic H7N9 Virus.Emerg Infect Dis2018
30007825Novel influenza vaccine M2SR protects against drifted H1N1 and H3N2 influenza virus challenge in ferrets with pre-existing immunity.Vaccine2018
29260686Characterization of a Feline Influenza A(H7N2) Virus.Emerg Infect Dis2018
29212927Mutations in the PA Protein of Avian H5N1 Influenza Viruses Affect Polymerase Activity and Mouse Virulence.J Virol2018
  • 1 - 50 of 171

Recommended Authors

Duke University School of Medicine
Career Start Year 2012
Number of shared co-authors 2
Institute of Medical Virology, University of Zurich
Career Start Year 2012
Number of shared co-authors 3
Institute of Virology, Freiburg University Medical Center, University of Freiburg
Career Start Year 2012
Number of shared co-authors 2
Indian Institute of Science
Career Start Year 2011
Number of shared co-authors 11
Sanford Burnham Prebys Medical Discovery Institute
Career Start Year 2010
Number of shared co-authors 4
Stanford University School of Medicine
Career Start Year 2010
Number of shared co-authors 3
Icahn School of Medicine at Mount Sinai
Career Start Year 2009
Number of shared co-authors 3
Icahn School of Medicine at Mount Sinai
Career Start Year 2008
Number of shared co-authors 6
Icahn School of Medicine at Mount Sinai
Career Start Year 2007
Number of shared co-authors 4
Sanford Burnham Prebys Medical Discovery Institute
Career Start Year 2006
Number of shared co-authors 4
Duke University School of Medicine
Career Start Year 2006
Number of shared co-authors 8
Merck & Co., Inc.
Career Start Year 2005
Number of shared co-authors 2
National Institute of Allergy and Infectious Diseases, National Institutes of Health
Career Start Year 2004
Number of shared co-authors 12
Institute of Medical Virology, University of Zurich
Career Start Year 2004
Number of shared co-authors 5
University of Iowa
Career Start Year 2002
Number of shared co-authors 11
Quantitative Biosciences Institute (QBI) Coronavirus Research Group (QCRG)
Career Start Year 2001
Number of shared co-authors 7
Korea University College of Medicine
Career Start Year 2001
Number of shared co-authors 3
Icahn School of Medicine at Mount Sinai
Career Start Year 2001
Number of shared co-authors 21
Washington State University
Career Start Year 2000
Number of shared co-authors 9
Icahn School of Medicine at Mount Sinai
Career Start Year 2000
Number of shared co-authors 7
University of California riverside
Career Start Year 1999
Number of shared co-authors 6
Icahn School of Medicine at Mount Sinai
Career Start Year 1999
Number of shared co-authors 1
University of Texas Medical Branch
Career Start Year 1996
Number of shared co-authors 8
University of Michigan ann arbor
Career Start Year 1995
Number of shared co-authors 9
Icahn School of Medicine at Mount Sinai
Career Start Year 1994
Number of shared co-authors 8
Icahn School of Medicine at Mount Sinai
Career Start Year 1993
Number of shared co-authors 9
Centers for Disease Control and Prevention.
Career Start Year 1989
Number of shared co-authors 30
University of California san francisco
Career Start Year 1981
Number of shared co-authors 6
Icahn School of Medicine at Mount Sinai
Career Start Year 1968
Number of shared co-authors 21
Institute of Virology, Philipps University
Career Start Year 1965
Number of shared co-authors 14

Collaborators

Influenza Research Institute, University of Wisconsin
Co-authored papers 156
Influenza Research Institute, University of Wisconsin-Madison
Co-authored papers 41
Influenza Research Institute, University of Wisconsin
Co-authored papers 23
Influenza Research Institute, University of Wisconsin-Madison
Co-authored papers 17
Harbin Veterinary Research Institute
Co-authored papers 17
FluGen Inc.
Co-authored papers 12
University of Washington
Co-authored papers 7
Pacific Northwest National Laboratory
Co-authored papers 7
University of North Carolina
Co-authored papers 7
Co-authored papers 6
Co-authored papers 6
Pacific Northwest National Laboratory
Co-authored papers 5
Institut des Agents Infectieux, Infective Agents Institute, North Hospital Network
Co-authored papers 5
Icahn School of Medicine at Mount Sinai
Co-authored papers 5
Pacific Northwest National Laboratory
Co-authored papers 5
Co-authored papers 5
European Bioinformatics Institute (EMBL-EBI)
Co-authored papers 5
Oregon State University
Co-authored papers 5
Pacific Northwest National Laboratory
Co-authored papers 5
Center for Innate Immunity and Immune Disease, University of Washington
Co-authored papers 4
National Institute of Allergy and Infectious Diseases, National Institutes of Health
Co-authored papers 4
Centers for Disease Control and Prevention (CDC)
Co-authored papers 4
Co-authored papers 4
Pacific Northwest National Laboratory
Co-authored papers 4
University of Pretoria
Co-authored papers 4
University of North Carolina at Chapel Hill
Co-authored papers 4
Icahn School of Medicine at Mount Sinai
Co-authored papers 4
Co-authored papers 4
Institute of Virology, Medical Center - University of Freiburg
Co-authored papers 4
Centers for Disease Control and Prevention
Co-authored papers 3